Recursion Pharmaceuticals Inc Cl A (RXRX)

RXRX stock results show that Recursion Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

The Top 3 Biotech Stocks to Buy in April 2024

By Joel Lim, InvestorPlace Contributor Apr 27, 2024

Learn about the top three biotech stocks to take advantage of these companies' promising futures and pharmaceutical advances.

Biotech on a Budget: 7 Stocks Under $10 With Huge Potential

By Josh Enomoto, InvestorPlace Contributor Apr 15, 2024

The broader medical therapeutic sector is already volatile so it stands to reason in some sense to consider under-$10 biotech stocks. Imagine you acquired shares…

Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for April 2024

By Viktor Zarev, InvestorPlace Contributor Apr 15, 2024

Through opportunity for growth and strong financial performance, these three Cathie Wood stocks could provide generous returns.

Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?

By Rich Duprey, InvestorPlace Contributor Mar 1, 2024

On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks.

Get Rich Quick With These 3 AI Stocks to Buy Now

By Matthew Farley, InvestorPlace Contributor Feb 18, 2024

Jump on the AI revolution with three AI stocks poised for rapid growth. Don't miss out on these potential wealth generators in the tech boom.

5 Stocks to Buy to Invest Like Nvidia

By Samuel O'Brient, InvestorPlace Reporter Feb 15, 2024

Do you want to invest like Nvidia? Here are the stocks to buy if you want to follow the chipmaker methodology and focus on AI exposure.

3 AI Stocks that Could be the Next Palantir

By Jeremy Flint, InvestorPlace Contributor Feb 15, 2024

These niche AI stocks are using Palantir's ascent as a roadmap to market dominance in their respective fields.

Cathie Wood Is Betting Big on Recursion Pharmaceuticals (RXRX) Stock

By Chris MacDonald, InvestorPlace Contributor Jan 9, 2024

Investors in Recursion Pharmaceuticals and RXRX stock have a couple of key catalysts to point to as reasons to buy big right now.

3 Biotech Stocks at the Forefront of the Quest for Eternal Youth

By Jeremy Flint, InvestorPlace Contributor Jan 2, 2024

Biotech stocks targeting longevity could uncover the fountain of youth in coming years, offering a prime investment opportunity today.

3 Genomics Stocks to Unlock the Future of Medicine

By Jeremy Flint, InvestorPlace Contributor Dec 19, 2023

Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.

AI Meets Biotech: 3 Top Stocks Transforming Medical Science

By John Blankenhorn, InvestorPlace Contributor Dec 16, 2023

The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology.

2024’s Hidden Gems: 7 Small-Caps Set for Explosive Growth

By Jeremy Flint, InvestorPlace Contributor Nov 23, 2023

Small-cap stocks outperform larger companies on an indexed basis, but finding the best among them individually isn't always easy

AI Alert: 3 Healthcare Stocks That Are Investing in Artificial Intelligence

By Ian Cooper, InvestorPlace Contributor Nov 9, 2023

We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom that's greatly impacting healthcare.

3 Stocks to Buy for Their Proximity to Nvidia

By Jeremy Flint, InvestorPlace Contributor Nov 8, 2023

Nvidia isn't the only AI stock on the market. These three companies stand to benefit from Nvidia's success while offering diversification.

The 7 Best Cathie Wood Stocks to Buy Now: November Edition

By Muslim Farooque, InvestorPlace Contributor Nov 1, 2023

Dive into the dynamic world of Cathie Wood stocks, wagering on the disruptive tech gems shaping tomorrow's investment landscape.

Recursion Pharmaceuticals Inc Cl A (RXRX)

3 Healthcare Stocks Injecting AI for Big Gains

3 Longevity Stocks to Buy for Anti-Aging Breakthroughs

3 Stocks This Amazon-Backed AI Says Will Turn $1K into $1M by 2030

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Recursion Pharmaceuticals Inc Cl A (RXRX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

RXRX Stock Predictions, Articles, and Recursion Pharmaceuticals Inc Cl A News

Subscriber Sign in